Impact Factor
4.75
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
8.17
87,657 total citations
h5-index
220
h5 depth signal
Cited share
89.3%
10,734 of 12,024
Total citations
87,657
Citation footprint
Metric signal
8.21
External metric anchor
Self-citation
6.8%
5,973 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
22,514
United States
9,891
Germany
4,016
Italy
2,499
United Kingdom
2,431
Citing Fields of Research
Immunology
32,695
Hematology
3,674
Virology
3,477
Oncology
3,411
Musculoskeletal Disorders
3,272
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
58,218
Articles tracked across the journal lifetime
Indexed publication set
12,024
10,734 cited publications
Last 12 months
9,741
811.8 publications/month
Open access share
100.0%
9,741 OA publications in the last year
Leading citing country
China
22,514 citing publications
Leading citing field
Immunology
32,695 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v9, 2018-
v1, 2010-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Broad Categories
Allergy and Immunology
Immunology
Virology
Musculoskeletal Disorders
Hematology
Cancer, Autophagy & Apoptosis
Inflammatory Bowel Diseases & Infections
MeSH Descriptors
Immune System Diseases
Immune System Phenomena
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.3389/fimmu.2026.2021485
Open DOI
Editorial: Sharpen the tools to decipher cell-cell communication better
02
DOI 10.3389/fimmu.2026.1918701
Open DOI
Effects of exercise therapy on balance, functional performance, and fall-related outcomes in community-dwelling older adults with chronic conditions: a systematic review and meta-analysis
Background: Community residents with chronic diseases face a higher risk of falls, functional decline, and loss of independence, constituting a significant public health burden. Exercise therapy is widely recommended; however, its effica...
03
DOI 10.3389/fimmu.2026.2020350
Open DOI
Editorial: Liver diseases – from pathophysiology to new treatment options
04
DOI 10.3389/fimmu.2026.1964020
Open DOI
Case Report: bullous pemphigoid during secukinumab treatment for plaque psoriasis: therapeutic challenges and long-term follow-up
Background: Bullous pemphigoid (BP) may occur during interleukin-17A inhibitor therapy in patients with psoriasis. Most reported cases have focused on BP onset and short-term management, with limited information on long-term outcomes and...
05
DOI 10.3389/fimmu.2026.1959178
Open DOI
Development and validation of the IFN-γ FlowCytoScreen for cytokine-based potency assessment of advanced therapy medicinal products
Introduction: Robust quality control methods are required to ensure the safety, efficacy and consistency of advanced therapy medicinal products. Potency assays play a critical role in evaluating their biological activity. While ELISpot r...
06
DOI 10.3389/fimmu.2026.1966044
Open DOI
IgM-and IgG-cleaving enzyme facilitates AAV gene transfer in AAV-seropositive macaques
AAV gene therapy is a promising approach for long-term delivery of antiviral proteins that can control HIV replication, but pre-existing circulating AAV-specific antibodies can preclude successful AAV transduction and pose a challenge fo...
07
DOI 10.3389/fimmu.2026.1980175
Open DOI
SPP1 promotes anoikis resistance and metastatic phenotypes in hepatocellular carcinoma through PI3K-sensitive signaling
Background: Anoikis resistance enables tumor cells detached from the extracellular matrix to survive during metastatic dissemination, yet its relationship with the immune microenvironment of hepatocellular carcinoma (HCC) remains incompl...
08
DOI 10.3389/fimmu.2026.1981826
Open DOI
Plasma CD55 and HIV RNA load in newly diagnosed antiretroviral therapy-naive adults: an exploratory hospital-based case-control study
Background: Plasma complement regulation during untreated HIV infection remains incompletely characterized. We examined complement markers in newly diagnosed, antiretroviral therapy (ART)-naive adults and their relationships with HIV RNA...
09
DOI 10.3389/fimmu.2026.1945180
Open DOI
Extracapsular and joint-dominant hand and wrist MRI patterns in psoriatic and rheumatoid arthritis: an exploratory case-control study
Background: Psoriatic arthritis (PsA) and rheumatoid arthritis (RA) may present with overlapping hand and wrist symptoms, while their anatomical patterns of inflammation differ. Objective: To compare prespecified hand and wrist magnetic ...
10
DOI 10.3389/fimmu.2026.1974216
Open DOI
Beyond platelet response: toward an immune remission framework in immune thrombocytopenia
Platelet response and clinical remission remain central measures of clinical control in immune thrombocytopenia (ITP), but they do not establish whether disease-relevant immune activity has durably receded. We propose immune remission as...